Product Wiki · Recalls · EU Safety Gate (RAPEX)

Montre — recall A12/00015/24

EU Safety Gate (RAPEX) · France · 2024-01-12 · Serious risk

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/00015/24
Date of alert
2024-01-12
Country / jurisdiction
France
Risk level
Serious risk
Risk type
Chemical
Brand
Elise&Lise
Product category
Jewellery
Product type
Watch
Barcode (EAN/GTIN)
3665789064697
Reported risk: The product releases an excessive amount of nickel (measured value up to 2.4 μg/cm²/week). Nickel is a strong sensitiser and causes allergic reactions if present in articles that come into direct and prolonged contact with the skin. The product also has an excessive concentration of lead (measured value up to 2.4 % by weight). Lead is harmful to human health, accumulates in the body, can cause developmental neurotoxicity (only if exposure to children expected) and may affect breast-fed or unborn children.
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from EU Safety Gate (RAPEX) →

Action taken by the authority
Type of economic operator taking notified measure
Distributor
Category of measure
Recall of the product from end users
Date of entry into force
11/11/2023
Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10011303

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.